Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 2
- 1
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Safe and prolonged survival with Long-term exposure to Pomalidomide in Relapsed/Refractory MyelomaAnnals of Oncology, 2016, 27 (5), pp.902-907. ⟨10.1093/annonc/mdw017⟩
Journal articles
hal-01263111v1
|
||
CARFILZOMIB WEEKLY PLUS MELPHALAN AND PREDNISONE IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA (IFM 2012-03) / 21st Congress of the European-Hematology-AssociationHaematologica, 2016, 101, pp.1--1
Journal articles
hal-01358590v1
|
|||
Le pomalidomide dans le myélome multipleLa Revue de Médecine Interne, 2015, 36 (9), pp.613-618. ⟨10.1016/j.revmed.2015.04.007⟩
Journal articles
hal-01187126v1
|